China Embodied AI Funding 2026
By Axis Intelligence Research
Co-authors: Mia Scarlett, Business and Capital Markets | Last updated: August 31, 2026 | License: CC BY 4.0
China’s embodied AI sector absorbed RMB 93.5 billion across 322 disclosed financing rounds in the first half of 2026, a fivefold increase on the same period a year earlier. According to Axis Intelligence Research, that capital equals roughly RMB 4.9 million for every humanoid robot the entire world shipped in those six months.
Quick Answer
China embodied AI funding reached RMB 93.5 billion (about US$13.8 billion) across 322 disclosed rounds in the first half of 2026, per ITJuzi data published through the Shanghai Stock Exchange — a fivefold rise in value and a 137% rise in deal count year on year. The sector added 19 new unicorns to the three it had at the end of 2025. According to Axis Intelligence Research, Capital per Shipped Unit (CPS) reads RMB 4,895,288 as of August 31, 2026 — the half-year funding total divided by global humanoid deliveries in the same period. That is 6.4 times the highest realized selling price any Chinese humanoid maker has disclosed.
Key Findings
- According to Axis Intelligence Research, China’s embodied AI sector raised RMB 4,895,288 of private capital for every humanoid robot delivered worldwide in the first half of 2026 — computed from ITJuzi’s RMB 93.5 billion funding total and Smart Analytics Global’s 19,100-unit global delivery estimate for the same six months.
- According to Axis Intelligence Research, that capital-per-unit figure runs 6.4 times UBTECH’s disclosed realized price of RMB 760,479 per full-size humanoid and 31.0 times Unitree’s RMB 157,818 — the two prices anchoring the only company-filed revenue-per-unit calculations available in this market.
- China’s embodied intelligence sector recorded 322 financing deals in the first half of 2026, up 137% year on year, with total disclosed value of RMB 93.5 billion, per ITJuzi figures carried by the Shanghai Stock Exchange on July 16, 2026.
- According to Axis Intelligence Research, Unitree Robotics allocated RMB 1.82 of planned IPO proceeds to embodied AI model development for every RMB 1.00 allocated to the robot body — a Brain-to-Body Allocation Ratio of 1.82, computed from the only line-item use-of-proceeds split any Chinese embodied AI issuer has published.
- According to Axis Intelligence Research, the entire proceeds of China’s largest robotics IPO equal 6.5% of what the sector raised privately in six months — Unitree’s RMB 6.099 billion Shanghai offering against RMB 93.5 billion of first-half private financing, which is why the private market, not the exchange, still sets valuations here.
How Much Money Has China’s Embodied AI Sector Raised in 2026?
The number that anchors everything else came out of ITJuzi, a Chinese investment data provider, and reached English-language readers through an exchange channel: the Shanghai Stock Exchange republished Yicai’s account of the first-half tally on July 16, 2026. China’s embodied artificial intelligence sector attracted RMB 93.5 billion — about US$13.8 billion — across 322 deals in the six months ended June 30, a fivefold jump in value and more than double the deal count of a year earlier. The Global Times, citing the same ITJuzi series, puts the deal-count increase precisely at 137%.
Set that against the two years before it. ITJuzi’s series, as reported by 36Kr, puts full-year 2024 embodied intelligence financing at just over RMB 10 billion and full-year 2025 at RMB 45.3 billion. On those figures, the first six months of 2026 raised 2.06 times what the sector raised in all of 2025, and roughly nine times what it raised in all of 2024.
China embodied AI funding, 2024 to first-half 2026
| Period | Disclosed financing | Deal count | Change on prior period | Source |
|---|---|---|---|---|
| FY 2024 | ~RMB 10bn | Not disclosed | — | ITJuzi, reported by 36Kr |
| FY 2025 | RMB 45.3bn | Not disclosed | 4.53x | ITJuzi, reported by 36Kr |
| H1 2026 | RMB 93.5bn (US$13.8bn) | 322 | 5x on H1 2025; deals +137% | ITJuzi, via Shanghai Stock Exchange |
| H1 2026 average deal size | RMB 290.4m | — | — | Axis Intelligence Research calculation |
Average disclosed round size across the half was RMB 290.4 million. That figure is doing less work than it looks: the distribution behind it is severely skewed, and the mean sits well above what a typical seed or angel round in this sector actually clears.
Mia Scarlett: A fivefold move in disclosed financing is the kind of number that gets quoted without its footnote, so here is the footnote. This is a media-and-database tally of announced rounds, not a regulatory filing series. Undisclosed amounts are excluded, announced-but-unclosed rounds are included, and a company that announces a B, B+ and B++ inside four months appears three times. The direction is not in dispute and the magnitude is corroborated across ITJuzi, Yicai and the exchange’s own republication. The decimal place is.
Source: Axis Intelligence Research — CC BY 4.0
What Does China’s Embodied AI Capital Actually Buy Per Robot?
This is the question the funding coverage does not answer, and it is the one an investor, a journalist and a policymaker all end up asking.
Two well-sourced numbers cover the same six months. Chinese embodied AI companies raised RMB 93.5 billion in the first half of 2026. Global humanoid robot deliveries in that same half came to approximately 19,100 units, per Smart Analytics Global — of which Chinese vendors supplied more than 97%. Divide the first by the second and you get the capital intensity of this market expressed in the only unit that matters to a customer.
The Axis Capital per Shipped Unit metric (CPS)
CPS — Capital per Shipped Unit is an original Axis Intelligence Research metric measuring how much private capital China’s embodied AI sector absorbs for each humanoid robot the world actually receives. It exists because funding totals and shipment totals are the two most-quoted figures in this sector and nobody puts them in the same sentence, which lets a story about capital formation pass as a story about commercial traction.
Formula, with inputs disclosed:
CPS = Disclosed China embodied AI financing, period
/ Global humanoid robot deliveries, same period
Baseline reading, August 31, 2026:
- Disclosed China embodied AI financing, H1 2026: RMB 93,500,000,000 (ITJuzi, via Shanghai Stock Exchange, July 16, 2026)
- Global humanoid robot deliveries, H1 2026: 19,100 units (Smart Analytics Global, August 2026)
93,500,000,000 / 19,100 = RMB 4,895,288 per unit
CPS = RMB 4,895,288 (approximately US$722,500) as of August 31, 2026. This is the metric’s first computed reading and serves as its baseline; it carries no history and makes no claim relative to one.
The multiple that gives it meaning. A capital figure per unit is only legible next to a price per unit. Two Chinese manufacturers disclose both a humanoid revenue line and a unit count, which makes their realized prices the only defensible denominators available:
| Comparison | Realized price per humanoid | CPS multiple | Basis | Source |
|---|---|---|---|---|
| UBTECH Robotics, FY2025 | RMB 760,479 | 6.44x | RMB 820.557m / 1,079 full-size units | HKEX annual results, Mar 31, 2026 |
| Unitree Robotics, FY2025 | RMB 157,818 (ceiling) | 31.02x | RMB 868m / 5,500+ humanoids | Unitree prospectus via SSE |
So China’s embodied AI sector raised, in six months, between six and thirty-one times as much capital per humanoid delivered as the machines themselves sold for. The spread between 6.4 and 31.0 is not noise — it is the difference between an industrial humanoid sold into an automotive line and a research-and-education unit, and it tells you the multiple depends entirely on which product mix eventually wins.
Scope of the reading. The numerator covers embodied AI broadly, including model developers, dexterous-hand makers, sensor firms and data-collection platforms that ship no humanoid at all. The denominator counts humanoid units only, globally rather than for China alone. CPS is therefore a capital-intensity indicator for the sector as a whole measured against its most visible physical output, not a per-company cost figure, and Axis Intelligence Research states that mismatch rather than smoothing it. A narrower humanoid-only numerator would lower the reading; a China-only denominator would raise it. The direction of the finding survives both adjustments.
Mia Scarlett: Capital intensity per unit of output is the first thing a credit analyst computes when a sector claims it is scaling, and it is conspicuously absent from every embodied AI funding write-up now in circulation. Nearly five million yuan of equity per delivered machine is not automatically a bubble reading — semiconductors, biotech and EVs all posted worse in their build-out years, and two of the three turned out fine. It is the number against which the 2027 shipment figures have to be judged. If deliveries triple and funding holds, CPS collapses and this sector earns its valuations. If both keep climbing together, the ratio is telling you something the press releases are not.
Where Is the Money Going Inside a Robot: Brains or Bodies?
The most consequential shift in China robotics funding in 2026 is not the total. It is that capital moved from the chassis to the model.
Look at what happens when a company is legally obliged to say where the money goes. Unitree Robotics’ prospectus registration document, disclosed by the Shanghai Stock Exchange on June 2, 2026, planned to raise RMB 4.202 billion, of which RMB 2.02 billion was earmarked for its intelligent robot model development project against RMB 1.11 billion for robot body research and development. Those two projects together account for 74.5% of the planned raise, and the model line exceeds the hardware line by RMB 910 million.
The Axis Brain-to-Body Allocation Ratio (BBAR)
BBAR — Brain-to-Body Allocation Ratio is an original Axis Intelligence Research metric measuring how a robotics issuer splits committed capital between embodied AI model development and physical robot development, using only line-item disclosures the company itself has published.
Formula, with inputs disclosed:
BBAR = Capital committed to embodied AI model / software R&D
/ Capital committed to robot body / hardware R&D
Baseline reading, August 31, 2026 (Unitree Robotics IPO, the only published split):
RMB 2,020,000,000 / RMB 1,110,000,000 = 1.82
BBAR = 1.82 as of August 31, 2026. For every yuan Unitree committed to the machine, it committed RMB 1.82 to the intelligence running it. This is a single-issuer reading because it is the only line-item split in the market: no other Chinese embodied AI company has published a comparable allocation, and Axis Intelligence Research will not construct one from press-release language.
What makes the reading more than a curiosity is that the private market moved the same way in the same quarter, in deals whose stated purpose is on the record:
| Company | Round | Amount | Stated use | Date | Source |
|---|---|---|---|---|---|
| Noin Intelligence | Angel++ | RMB 500m (US$74.1m) | Generalizable embodied AI models, GLOW generative model iteration | Aug 10, 2026 | Company statement via Global Times |
| DISCOVER Robotics | Angel+ | US$100m | ORION foundation model, LOOP data closed-loop, DISCOVERSE simulator | Aug 3, 2026 | Wuxi municipal government WeChat, via Global Times |
| Ant Lingbo (Ant Group) | First round, sought | RMB 1.5bn | General-purpose robotic brains, embodied-native technology | Aug 3, 2026 | Company confirmation, via Global Times |
| Galbot | New round | RMB 2.5bn (US$350m) | Energy, manufacturing and real-estate applications | Mar 2, 2026 | Company WeChat, via Global Times |
| XPENG Robotics | First external round | >US$900m | Physical AI model training, mass production facilities | Aug 24, 2026 | Company press release |
Yicai’s analysis of the half reached the same conclusion from the other direction, identifying three concentration points for the capital: embodied AI large-model R&D, large-scale robot training data collection, and product delivery capability. Two of those three are software.
Mia Scarlett: Follow the use-of-proceeds line and you learn what management actually believes, because that line is the one the underwriters make them defend. Unitree spent 2025 being described as a hardware company and then wrote a prospectus that puts 1.82 yuan of model spending behind every yuan of body spending. Read that as guidance. The hardware differentiation in this sector has a short half-life — 76 degrees of freedom becomes table stakes in eighteen months — and the people writing the cheques have worked that out.
Who Are the Biggest Investors in China’s Embodied AI Startups?
The cap tables in this sector have an unusual shape: state industrial funds, internet platforms and classical venture capital sit in the same rounds, and the state fund is often the signal the others follow.
The National Artificial Intelligence Industry Investment Fund, launched in 2025 with a stated scale of RMB 60 billion, made its first embodied intelligence investment in Galbot’s RMB 2.5 billion round announced on March 2, 2026, alongside China Petroleum and Chemical Corporation and CITIC Investment Holdings. It has since also backed Deep Robotics. Local government capital is broader still: Shenzhen Capital Group alone has funded at least twelve companies in the sector, and automotive industrial investors including SAIC Motor and BAIC Group Industrial Investment have written cheques into embodied AI firms.
Among private institutions, the first-half concentration is severe. HongShan participated in 20 financing rounds across 14 companies. GL Ventures, Hillhouse’s early-stage arm, took part in 18 rounds across 14 companies. Among the internet platforms, Meituan and its affiliates were the most active, backing seven companies including X Square Robot, Galaxea AI and TARS Robotics.
Most active investor groups, H1 2026
| Investor | Activity | Category | Source |
|---|---|---|---|
| HongShan | 20 rounds, 14 companies | Venture capital | ITJuzi / Yicai, via SSE |
| GL Ventures (Hillhouse) | 18 rounds, 14 companies | Venture capital | ITJuzi / Yicai, via SSE |
| Meituan and affiliates | 7 companies | Internet platform | Yicai, via SSE |
| Shenzhen Capital Group | At least 12 companies | Local state capital | Yicai, via SSE |
| National AI Industry Investment Fund | Galbot, Deep Robotics | National state capital | Yicai, via SSE; Global Times |
| Tencent, Alibaba, JD.com | Multiple rounds each | Internet platform | Yicai, via SSE |
One company sits at the intersection of every platform strategy: X Square Robot is the only Chinese embodied AI firm backed by Meituan, Alibaba, ByteDance and Xiaomi simultaneously.
The single largest cheque in the sector’s history came from outside that ecosystem entirely. XPENG announced on August 24, 2026 that its robotics business raised over US$900 million at a post-money valuation above US$6.3 billion, led by IDG Capital with Gaorong Ventures participating and Tencent and Alibaba as strategic investors — which the company describes as the largest single-round private financing ever recorded in China’s embodied AI industry. That round sold roughly 14.3% of the robotics business, and the company states the funding will support Physical AI model training, high-quality data generation and end-to-end mass production facilities, with IRON entering mass production by the end of 2026 and customer deliveries in 2027.
How Many Embodied AI Unicorns Does China Have?
Twenty-two, by the count that can be traced to a named source.
Unitree Robotics, AgiBot and Galbot each passed RMB 10 billion in valuation during 2025, making them the sector’s first embodied AI unicorns. In the first half of 2026 they were joined by 19 more, including Deep Robotics, X Square Robot, AI² Robotics, Galaxea AI and Spirit AI. Four of the cohort — Galbot, X Square Robot, AI² Robotics and Galaxea AI — have each cleared RMB 20 billion.
Chinese embodied AI unicorn formation
| Metric | Value | As of | Source |
|---|---|---|---|
| Unicorns (>RMB 10bn valuation) at end-2025 | 3 | Dec 31, 2025 | Yicai, via SSE |
| New unicorns added | 19 | H1 2026 | Yicai, via SSE |
| Cumulative unicorns | 22 | Jun 30, 2026 | Axis Intelligence Research calculation |
| Companies above RMB 20bn | 4 | Jun 30, 2026 | Yicai, via SSE |
| Largest single private round | US$900m+ at US$6.3bn+ post-money | Aug 24, 2026 | XPENG press release |
Twenty-two unicorns created inside eighteen months, in a category whose global unit deliveries for the half were 19,100 machines, works out to roughly one unicorn per 868 humanoid robots the world received.
Mia Scarlett: Unicorn counts are a poor proxy for industrial health and a good proxy for how fast a valuation methodology is spreading. What the RMB 20 billion cluster tells you is that a small group of companies has established a price band, and that band is now being applied to the next cohort by comparison rather than by cash flow. Three of the four firms above RMB 20 billion publish no revenue at all. That is a normal condition for a private company and an abnormal condition for a company being valued at the level of a listed industrial.
Is China’s Embodied AI Funding Rotating From Private Markets to IPOs?
It is trying to, and the arithmetic shows how early that rotation still is.
Ten robotics-related companies listed in Hong Kong in the first half of 2026, with another 16 filed and awaiting approval per Choice data. By August, the Global Times reported the pipeline had widened further: citing Wind data via the China STAR Market, five robotics-related companies had gone public in Hong Kong so far in 2026 under that narrower classification, while 51 companies spanning industrial robots, service robots and embodied intelligence solutions sat in the Hong Kong IPO queue — 12.7% of everything awaiting listing. Axis Intelligence Research notes the two counts use different definitions of “robotics-related” and does not reconcile them; both are stated with their source.
On the mainland, Unitree, Deep Robotics, Dobot and Leju Robotics have all entered the IPO process. Unitree got there first, and its numbers set the benchmark the rest will be priced against.
Unitree Robotics IPO, the sector’s first public price
| Item | Value | Source |
|---|---|---|
| Offer price | RMB 150.80 per share | SSE announcement, Aug 6, 2026 |
| New shares issued | 40,446,400 (10% of post-issue capital) | SSE announcement |
| Gross proceeds | RMB 6.099bn | Axis Intelligence Research calculation |
| Original target raise | RMB 4.202bn | Prospectus registration, Jun 2, 2026 |
| Raise above target | RMB 1.897bn (+45.1%) | Axis Intelligence Research calculation |
| Valuation at listing | ~RMB 61bn (US$9.04bn) | Global Times, Aug 9, 2026 |
| Model R&D allocation | RMB 2.02bn | Prospectus registration |
| Robot body R&D allocation | RMB 1.11bn | Prospectus registration |
The rotation is real but small. Axis Intelligence Research measures it directly: RMB 6.099 billion of IPO proceeds against RMB 93.5 billion of first-half private financing is 6.5%. Even China’s largest robotics listing, priced at a valuation that briefly made Unitree worth more on paper than several established internet companies, raised one-fifteenth of what the private market wrote in six months. Public markets are currently a liquidity event for early investors in this sector, not its funding mechanism.
Two secondary-market readings from the same window are worth stating with their caveat attached: RobotPhoenix drew 14,855-fold oversubscription on listing and LDRobot rose 127.62% on its first day. As Tian Feng, former dean of SenseTime’s Intelligence Industry Research Institute, told the Global Times, oversubscription multiples carry no direct relationship to product delivery certainty. Axis Intelligence Research agrees, and adds the mechanical reason: both figures measure the scarcity of the float, not the depth of the order book for the product.
Why Is Beijing Backing Embodied AI So Heavily?
Because the plan says to, in writing, with a budget line behind it.
Embodied artificial intelligence is named as one of China’s designated “industries of the future” in the government work report delivered to the National People’s Congress on March 5, 2026, alongside future energy, quantum technology, brain-computer interfaces and 6G. The draft outline of the 15th Five-Year Plan submitted the same day places embodied AI among the new drivers of economic growth for the 2026 to 2030 period, with robotics listed separately among the emerging strategic industries to be accelerated.
That designation is why the National AI Industry Investment Fund appears on cap tables, why Shenzhen Capital Group has a dozen positions, and why local government WeChat accounts announce angel rounds. Capital allocation in this sector is not purely a market process.
It also comes with a timeline that the funding pace does not match. In its assessment of the same plan, the International Federation of Robotics observed that real-world humanoid capability remains confined to demonstrators and pilot projects, and that the plan itself situates humanoid commercialization toward the end of the 2026 to 2030 period. Beijing’s own document does not expect commercial maturity before roughly 2030. The capital arrived four years early.
Context for the scale question: the Ministry of Industry and Information Technology counted more than 140 humanoid robot manufacturers in China in 2025, having launched more than 330 related products. The RMB 93.5 billion is being spread across a field that dense.
Mia Scarlett: The interesting tension in this sector is not between bullish and bearish investors. It is between the funding cadence and the state’s own published schedule. When policy says late-decade commercialization and capital says eighteen-month unicorn cycles, one of the two is going to be restated. Liu Yinghang of Scale Partners put the risk plainly to Yicai: as valuations continue to rise, the bubble gets bigger unless embodied AI gets deployed against real problems. That is not a short-seller talking. It is the advisory side of the same market that is writing the cheques.
Methodology
Collection. Every figure in this article was read from a source document fetched during production on August 31, 2026, and every figure appears as a row in the accompanying CSV with its source organization, source document, URL and retrieval date. Funding aggregate figures originate with ITJuzi and reach this article through the Shanghai Stock Exchange’s republication of Yicai’s July 14, 2026 report and through Global Times reporting of August 9 and 10, 2026. Company round data comes from company statements and press releases as reported by Global Times, and from XPENG’s own press release. Policy designations come from the Chinese government’s English-language publication of the March 5, 2026 government work report and 15th Five-Year Plan draft outline. Humanoid shipment figures come from Smart Analytics Global and are labeled estimates. Realized price per humanoid inputs come from UBTECH’s HKEX annual results announcement and Unitree’s prospectus figures published through the Shanghai Stock Exchange.
Source hierarchy. Government publications and exchange-hosted disclosures rank above state media reporting of company statements, which ranks above research-firm and database estimates. Where a figure originates with a commercial database such as ITJuzi, the CSV marks is_primary = no and the prose names the provider.
Formulas.
- CPS (Capital per Shipped Unit) = disclosed China embodied AI financing / global humanoid deliveries, same period. H1 2026: 93,500,000,000 / 19,100 = RMB 4,895,288.
- CPS multiple = CPS / realized price per humanoid. UBTECH basis: 4,895,288 / 760,479 = 6.44. Unitree basis: 4,895,288 / 157,818 = 31.02.
- BBAR (Brain-to-Body Allocation Ratio) = model and software R&D allocation / robot body R&D allocation, from published use of proceeds. Unitree: 2,020,000,000 / 1,110,000,000 = 1.82.
- Average disclosed round size = 93,500,000,000 / 322 = RMB 290.4 million.
- IPO share of sector funding = 6,099,000,000 / 93,500,000,000 = 6.5%.
- Unitree gross proceeds = 40,446,400 shares x RMB 150.80 = RMB 6.099 billion. Implied valuation check: 404,464,000 post-issue shares x RMB 150.80 = RMB 60.99 billion, consistent with the approximately RMB 61 billion reported.
- Cumulative unicorns = 3 (end-2025) + 19 (H1 2026) = 22.
All arithmetic was computed twice independently before the prose was written.
Definitions and method. ITJuzi’s funding series counts disclosed rounds, including rounds announced without a closed amount being excluded from the value total and including multiple rounds by the same company within the period. It is a database tally, not a regulatory dataset. The CPS numerator covers embodied AI companies broadly while the denominator counts humanoid units globally; the mismatch is stated in the CPS section and does not reverse the finding under either narrowing. BBAR is a single-issuer reading because only one Chinese embodied AI company has published a line-item use-of-proceeds split. Valuation figures for private companies are as reported by the companies or their investors and are not independently verifiable. Hong Kong IPO pipeline counts from Choice and from Wind use different classifications of “robotics-related” and are reported separately rather than merged.
Currency. Figures are stated in renminbi as reported. The single conversion applied by Axis Intelligence Research uses the rate implied by Yicai’s own pairing of RMB 93.5 billion with US$13.8 billion, which is 6.775 CNY/USD as of July 14, 2026, disclosed here rather than applied silently. Dollar figures elsewhere appear only where the source stated them in dollars.
About This Dataset
china-embodied-ai-funding-2026.csv contains every quantitative claim in this article as a tidy long-format table: one row per observation, with metric, entity, value, unit, as_of_date, geography, segment, source_org, source_document, source_url, retrieved_date, is_primary, axis_calculated, method_note and license. Temporal coverage: 2024 to 2027, with forward-looking items flagged. Spatial coverage: China, with global comparators.
License: CC BY 4.0. Free to use, redistribute and build on with attribution.
Citation line: Axis Intelligence Research, China Embodied AI Funding 2026, 2026.
Citation formats
APA — Axis Intelligence Research. (2026). China embodied AI funding 2026: RMB 93.5 billion, 322 rounds, and what capital paid per robot. https://axis-intelligence.com/china-embodied-ai-funding/
MLA — Axis Intelligence Research. “China Embodied AI Funding 2026: RMB 93.5 Billion, 322 Rounds, and What Capital Paid Per Robot.” Axis Intelligence Research, 31 Aug. 2026, axis-intelligence.com/china-embodied-ai-funding/.
Chicago — Axis Intelligence Research. “China Embodied AI Funding 2026: RMB 93.5 Billion, 322 Rounds, and What Capital Paid Per Robot.” Axis Intelligence Research, August 31, 2026. https://axis-intelligence.com/china-embodied-ai-funding/.
Frequently Asked Questions
How much did Chinese embodied AI startups raise in the first half of 2026?
RMB 93.5 billion, or about US$13.8 billion, across 322 disclosed financing deals, per ITJuzi data published through the Shanghai Stock Exchange on July 16, 2026. That is a fivefold increase in value on the first half of 2025 and a 137% increase in deal count. It also exceeds the sector’s entire full-year 2025 total of RMB 45.3 billion by a factor of 2.06.
What is Capital per Shipped Unit and why does it matter for embodied AI?
CPS is an Axis Intelligence Research metric dividing disclosed China embodied AI financing by global humanoid robot deliveries in the same period. Its baseline reading is RMB 4,895,288 as of August 31, 2026. It matters because funding totals and shipment totals are the two most-cited figures in this sector and are almost never divided by each other, which lets capital formation be reported as if it were commercial traction. At 6.4 times the highest disclosed selling price for a Chinese humanoid, CPS is the number a 2027 shipment forecast has to justify.
Which investors are backing Chinese embodied AI startups most actively?
HongShan led on round count with 20 rounds across 14 companies in the first half of 2026, followed by Hillhouse’s GL Ventures with 18 rounds across 14 companies. Meituan and its affiliates were the most active internet platform, backing seven companies. On the state side, the National AI Industry Investment Fund has invested in Galbot and Deep Robotics, and Shenzhen Capital Group has funded at least twelve companies. X Square Robot is the only Chinese embodied AI firm backed by Meituan, Alibaba, ByteDance and Xiaomi together.
Is Chinese embodied AI capital going into robot hardware or into AI models?
Increasingly into models. Unitree’s IPO registration document allocated RMB 2.02 billion to intelligent robot model development against RMB 1.11 billion for robot body R&D, a Brain-to-Body Allocation Ratio of 1.82 by Axis Intelligence Research’s calculation. The private market moved the same way in August 2026: Noin Intelligence raised RMB 500 million for generalizable embodied AI models, DISCOVER Robotics raised US$100 million for its ORION foundation model and simulation stack, and Ant Group’s Ant Lingbo sought RMB 1.5 billion for general-purpose robotic brains.
What was the largest embodied AI funding round in China?
XPENG’s robotics business raised over US$900 million at a post-money valuation above US$6.3 billion, announced August 24, 2026 and led by IDG Capital with Gaorong Ventures participating and Tencent and Alibaba as strategic investors. XPENG states this is the largest single-round private capital raise in China’s embodied AI industry to date. The round sold approximately 14.3% of the robotics business, which had no humanoid units in customers’ hands at the time.
How many Chinese embodied AI companies are worth more than RMB 10 billion?
Twenty-two. Unitree Robotics, AgiBot and Galbot crossed that threshold during 2025, and 19 more joined them in the first half of 2026, including Deep Robotics, X Square Robot, AI² Robotics, Galaxea AI and Spirit AI. Four of those companies — Galbot, X Square Robot, AI² Robotics and Galaxea AI — have each cleared RMB 20 billion. Most publish no revenue figures.
Are Chinese robotics companies raising more from IPOs or from private investors?
Private investors, by a wide margin. Unitree’s Shanghai listing, the largest robotics IPO in the mainland market, raised RMB 6.099 billion — 6.5% of what the sector raised privately in the first half of 2026. Ten robotics-related companies listed in Hong Kong in the first half with 16 more filed, and by August the Hong Kong queue held 51 robotics and embodied intelligence companies, 12.7% of everything awaiting listing. The listings are creating exits, not funding the industry.
How much did Unitree raise in its IPO and where is that money going?
Unitree issued 40,446,400 shares at RMB 150.80, raising RMB 6.099 billion against an original target of RMB 4.202 billion, a 45.1% overshoot. Of the originally planned proceeds, RMB 2.02 billion was allocated to intelligent robot model development and RMB 1.11 billion to robot body R&D. The offering valued the company at approximately RMB 61 billion, or US$9.04 billion, at listing.
What role does the Chinese government play in embodied AI funding?
A direct and a designating one. Embodied artificial intelligence is named as an industry of the future in the government work report delivered on March 5, 2026 and in the 15th Five-Year Plan draft outline submitted the same day. Behind that designation sits capital: the National AI Industry Investment Fund, launched in 2025 at a stated scale of RMB 60 billion, made its first embodied intelligence investment in Galbot’s RMB 2.5 billion round in March 2026, and provincial and municipal vehicles including Shenzhen Capital Group hold at least a dozen positions.
Does the funding pace match China’s own commercialization timeline?
No, and the gap is the sector’s central risk. The International Federation of Robotics reads the 15th Five-Year Plan as placing humanoid commercialization toward the end of the 2026 to 2030 period, with current real-world capability still confined to demonstrators and pilots. Capital is running on an eighteen-month unicorn cycle against a policy document that expects maturity around 2030. MIIT counted more than 140 humanoid manufacturers in China in 2025, so the money is also being spread across a very dense field.
Related Axis Intelligence Research
- China Humanoid Robot Statistics — output, shipments and the absorption gap between capacity and commercial placement
- China Humanoid Robot Companies — vendor shipments, revenue per robot and the disclosure gap
- Unitree Robotics Statistics — company financials, shipments and listing data
- China AI Statistics